TrialInternational journal of chronic obstructive pulmonary disease

Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease.

Ayse Dudu Altintas Dogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.